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Edema and ascites in nephrotic syndrome mainly result from increased Na reabsorption along connecting tubules and
cortical collecting ducts (CCD). In puromycin aminonucleoside (PAN)-induced nephrosis, increased Na reabsorption is
associated with increased activity of the epithelial sodium channel (ENaC) and Na,K-ATPase, two targets of aldosterone.
Because plasma aldosterone increases in PAN-nephrotic rats, the aldosterone dependence of ENaC activation in PAN
nephrosis was investigated. For this purpose, (1) the mechanism of ENaC activation was compared in nephrotic and
sodium-depleted rats, and (2) ENaC activity in PAN-nephrotic rats was evaluated in the absence of hyperaldosteronemia. The
mechanism of ENaC activation was similar in CCD from nephrotic and sodium-depleted rats, as demonstrated by (1) increased
number of active ENaC evaluated by patch clamp, (2) recruitment of ENaC to the apical membrane determined by immuno-
histochemistry, (3) shift in the electrophoretic profile of -ENaC, and (4) increased abundance of -ENaC mRNA. Cortico-
steroid clamp fully prevented all PAN-induced changes in ENaC but did not alter the development of a full-blown nephrotic
syndrome with massive albuminuria, amiloride-sensitive sodium retention, induction of CCD Na,K-ATPase, and ascites.
It is concluded that in PAN-nephrosis, (1) ENaC activation in CCD is secondary to hyperaldosteronemia, (2) sodium retention
and induction of Na,K-ATPase in CCD are independent of hyperaldosteronemia, and (3) ENaC is not necessarily limiting
for sodium reabsorption in the distal nephron.
I nterstitial edema observed in nephrotic syndrome resultsfrom primary renal Na retention and secondary capillaryfluid leakage. In puromycin aminonucleoside (PAN)-in-
duced nephrosis, renal sodium retention mainly originates
from connecting tubules and collecting ducts (1). In these
nephron segments, Na is reabsorbed by principal cells via
passive apical entry through amiloride-sensitive epithelium so-
dium channels (ENaC) and active basolateral extrusion by
sodium pumps. In cortical collecting ducts (CCD) of PAN-
nephrotic rats, high transepithelial Na transport (2) is associ-
ated with activation of ENaC through increased targeting of its
, , and  subunits to the apical membrane (3) and de novo
synthesis and increased targeting of  and  Na,K-ATPase
subunits to the basolateral membrane (4,5). Consistent with
these findings, the ENaC inhibitor amiloride fully abolishes
increased sodium transport in in vitro microperfused CCD and
prevents sodium retention in vivo in PAN-nephrotic rats (2).
Aldosterone is the major sodium retaining hormone in the
distal tubule. In CCD, aldosterone increases both ENaC and
Na,K-ATPase activities through a biphasic mode: In the
short term, it increases the targeting of intracellular pools of
ENaC and Na,K-ATPase to the apical and basolateral mem-
brane, respectively (6,7), and in a later phase, it increases the
cellular amount of ENaC and Na,K-ATPase (8,9). Because
plasma aldosterone level is increased in PAN-nephrotic rats at
the time of sodium retention (3,10,11), it is usually assumed that
hyperaldosteronemia mediates sodium retention in PAN ne-
phrosis. Therefore, we investigated whether activation of ENaC
in the CCD during PAN nephrosis is secondary to hyperaldo-
steronemia.
For this purpose, (1) we compared the mechanism of ENaC
activation in PAN nephrosis and in sodium restriction–induced
hyperaldosteronemia, and (2) we evaluated whether ENaC was
activated during PAN nephrosis in corticosteroid-clamped rats.
Activation of ENaC was assessed through its functional activ-
ity, gene expression, subcellular distribution, and electro-
phoretic mobility of its  subunit.
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Materials and Methods
Animals
Experiments were performed on either normal (adrenal-intact) or
corticosteroid-clamped male Sprague-Dawley rats (120 to 130 g). Cor-
ticosteroid clamp was achieved by bilateral adrenalectomy and supple-
mentation with 10 g/kg per d aldosterone and 14 g/kg per d
dexamethasone through subcutaneous osmotic pump (12). Nephrosis
was induced by a single injection of PAN (150 mg/kg body wt, intra-
peritoneally) performed the day after surgery in corticosteroid-clamped
animals. Hyperaldosteronemia was induced in adrenal-intact rats by a
single administration of furosemide (200 mg/kg in drinking water) at
day 0 followed by a low-sodium diet during 6 d (mean sodium intake
0.25  0.08 mmol/kg body wt per d). All other rats were fed the usual
laboratory diet ad libitum (mean sodium intake 8.6  0.2 and 6.2  0.9
mmol/kg body wt per d in control and PAN-nephrotic rats, respec-
tively). Nephrotic rats were studied 6 d after PAN administration,
when sodium retention and proteinuria were fully developed (13).
Sodium-deprived rats were studied 6 d after the onset of the treatment.
At that time, their urinary sodium excretion was drastically reduced as
compared with control rats: Low-Na 4.2  1.3 mmol Na/mmol creat-
inine (n  6); control 24.0  0.5 mmol Na/mmol creatinine (n  4).
For metabolic studies, starting 2 d before PAN administration, rats
were housed in metabolic cages and 24-h urine was collected for
measurement of sodium, creatinine, and proteins. Urinary sodium and
protein excretions were calculated as a function of urinary creatinine
excretion. The daily urinary sodium balance was calculated as the
difference between dietary sodium intake and urinary excretion. Six
days after PAN injection, animals were killed for measurement of
ascites volume and plasma aldosterone by RIA.
Isolation of Tubules
CCD were dissected from collagenase-treated kidneys as described
previously (13). For RNA extraction, tubules were isolated under
RNase-free conditions (14), and for patch-clamp and Western blot
analysis, antiproteases (PMSF 0.6 mM and leupeptin 0.2 M) were
added to the dissection solution.
Figure 1. Recording properties of epithelial sodium channel (ENaC) in the cell-attached configuration in cortical collecting ducts
(CCD) from adrenal-intact and corticosteroid-clamped rats. (A) Percentage of patches that contained ENaC in CCD from control
(), puromycin aminonucleoside (PAN) nephrotic (f), and Na-depleted rats (o) in either adrenal-intact or corticosteroid
(CS)-clamped conditions. Values in the columns indicate the total number of patches. (B) Number of channels per patch in the
same groups of rats; F, individual values; dotted lines, mean values. (C) Total number of channels detected throughout the study
in the different groups of rats. (D) Open state probability (Po) in the five groups; values in columns indicate the number of patches
used for determination of Po.
Table 1. Conductive properties of ENaCa
G Cell
Attached (pS) Er (mV)
Adrenal intact
control 9.6  1.1 (11) 69  17 (11)
PAN nephrosis 10.7  1.1 (8) 40  6 (8)
Na depleted 9.5  0.6 (11) 52 5 (11)
Corticosteroid clamped
control 9.8  1.3 (3) 55  5 (3)
PAN nephrosis 9.7 (1) 82 (1)
aConductive properties of ENaC were determined under
cell-attached conditions. ENaC, epithelial sodium channel; G,
unitary conductance; Er, apparent reversal potential. Values




Experimental methods were essentially the same as described previ-
ously (15). CCD that were placed in a perfusion chamber that was
mounted on an inverted microscope were slit-opened manually using a
sharpened pipette. The bath solution contained (in mM) 140 NaCl, 4.8
KCl, 1 CaCl2, 1.2 MgCl2, 10 glucose, and 10 HEPES and was adjusted to
pH 7.4 with NaOH. The patch pipettes were filled with a solution that
contained (in mM) 145 LiCl, 1.2 MgCl2, 10 glucose, and 10 HEPES,
adjusted to pH 7.4 with NaOH. Channel activity was measured from
digitized stretches of recording lasting at least 30 s. Experiments were
carried out at room temperature (22 to 27°C).
Antibodies
Polyclonal antibodies against , , and  subunits of rat ENaC were
produced in rabbits (Neosystem, Strasbourg, France) using specific
peptides that were described previously (8): NH2-LGKGDKREEQGL-
GPEPSAPRQPTC-COOH (amino acids 46 to 68), NH2-CNYDSLRLQ-
PLDTMESDSEVEAI-COOH (amino acids 617 to 638), and NH2-CNTL-
RLDRAFSSQLTDTQLTNEL-COOH (amino acids 629 to 650) for -, -,
and -ENaC, respectively. Antisera were affinity-purified on EAH-
Sepharose 4B (Pharmacia, Paris, France) and eluted with acetate buffer
(pH 4) that contained 0.5 M NaCl, formate buffer (pH 3), and finally
HCl (pH 1). Acidic fractions were adjusted to pH 7 and immediately
completed with Na azide (3 mM) and BSA (500 g/ml).
Immunoblotting
Kidneys were perfused with ice-cold homogenization solution (250
mM sucrose, 10 mM triethanolamine, 0.6 mM PMSF, and 0.2 M
leupeptin). The cortex was dissected from both kidneys, weighed, and
homogenized in 5 vol (vol/wt) of homogenization solution at 0 to 4°C
using a Teflon/glass Potter. Protein concentration was adjusted to the
same values in all samples with homogenization solution and later
controlled with loading gels stained with Coomassie blue.
Samples were solubilized at 60°C for 20 min after addition of 1 vol of
2 Laemmli. SDS-PAGE was performed on 8% polyacrylamide gels.
Proteins were electrotransferred to polyvinylidene difluoride mem-
branes (Polyscreen; NEN, Boston, MA), which were stained with Pon-
ceau S solution (Sigma France, Saint Quentin Fallavier, France) to check
transfer efficiency among samples. After casein blocking, blots were
incubated successively with anti–-ENaC antibody (HCl fraction) and
goat anti-rabbit IgG antibody coupled to horseradish peroxidase (Pro-
mega France, Charbonnie`res, France) and revealed by chemilumines-
cence with the Western Lightning Chemiluminescence reagent Plus
(PerkinElmer Life Science, Courtabeuf, France). Densitometry of the
different bands was quantified by scanning (Image J; National Insti-
tutes of Health, Bethesda, MD). Groups of rats were compared by
variance analysis; P  0.05 was considered as statistically different.
Immunocytochemistry
After anesthesia, the kidneys of rats (n  5 per group) were perfu-
sion-fixed with 150 ml of fixation solution that contained 3% (wt/vol)
paraformaldehyde and 0.05% picric acid, in a 3:2 mixture of 0.1 M
cacodylate buffer (pH 7.4, adjusted to 300 mOsmol/kgH2O with su-
crose) and 10% hydroxyethyl starch in saline. After a 5-min fixation and
a 5-min rinsing period with the cacodylate buffer, the kidneys were
removed, sliced, and frozen in liquid propane.
Figure 2. Absorption test for immunofluorescence staining and immunoblots of -, -, and -ENaC subunits in rat kidney cortex.
(A) Kidney cortex sections from control rats were incubated with the antibodies directed against each of the three subunits of
ENaC without (a, c, and e) or after preincubation with the immunizing peptide (b, d, and f). P, proximal tubule; CN, connecting
tubule located in the cortical labyrinth; CD, cortical collecting duct located in the medullary ray; bar is approximately 100 m. (B)
Immunoblots of kidney cortex homogenates from control (C) and PAN-nephrotic rats (PAN) with antibodies against each of the
three subunits of ENaC without (Antibody) or after preincubation with the immunizing peptide (Block).
3
Serial 4-m cryosections were pretreated with 10% normal goat
serum in PBS, incubated overnight at 4°C with ENaC antibodies (for-
mate fractions, 1:300), and revealed with a Cy3-conjugated goat anti-
rabbit IgG (Jackson Immuno Research Laboratories, West Grove, PA).
For each rat, at least five coronal sections of the kidneys were analyzed.
Controls of unspecific binding of primary and secondary antibodies
were performed by preincubating immune sera with the respective
immunogenic peptide or by omitting the primary antibodies.
Real-Time PCR
RNA were extracted from pools of 20 to 50 microdissected CCD
according to the technique previously described (14). After purification,
RNA were dissolved in 10 l of water that contained 40 U/ml RNAsin
(Promega, Madison, WI). RNA that were extracted from whole kidney
cortex using the same protocol served as internal standard for PCR.
Reverse transcription was performed on 8 l of tubular RNA extract
using the first-strand cDNA synthesis kit for reverse transcription–PCR
(Roche Diagnostics, Meylan, France), according to the manufacturer’s
protocol. The remaining 2 l of RNA extract was processed in parallel
in the absence of reverse transcriptase and served as controls (RTneg).
Real-time PCR was performed on a LightCycler (Roche Diagnostics)
with the LightCycler FastStart DNA Master SYBR Green 1 kit (Roche
Diagnostics) according to the manufacturer’s protocol, except that the
reaction volume was reduced to 8 l. PCR was performed in the
presence of cDNA that corresponded to 0.1 mm of nephron. After PCR,
the absence of contaminating PCR products was checked by a fusion
curve. No DNA was detectable in RTneg samples and in blanks run in
the absence of DNA. In each experiment, a standardization curve was
made using serial dilutions (1 to 1:100) of the standard cDNA stock
solution made from kidney cortex RNA (dilution 1 corresponded to
DNA produced from 16 ng of RNA). For all samples, the amount of
PCR product was calculated as percentage of the standard RNA. Re-
sults (arbitrary unit per mm tubule length) are expressed as means 
SEM from several animals. Specific primers (sequences available on
request) were designed using ProbeDesign (Roche Diagnostics).
Na,K-ATPase Assay
Na,K-ATPase activity was determined on pools of four to six
permeabilized CCD by the previously described microassay (13). Total
ATPase activity was determined in a solution that contained 100 mM
NaCl, 5 mM KCl, 10 mM MgCl2, 1 mM EDTA, 100 mM Tris-HCl, 10
mM Na2ATP, and 5 nCi/l [-
32P]ATP (Dupont, Boston, MA; 2 to 10
Ci/mmol) at pH 7.4. For Na,K-independent ATPase activity mea-
surements, NaCl and KCl were omitted, Tris HCl was 150 mM, and 2
mM ouabain was added. Na,K-ATPase activity was taken as the
difference between total and Na,K-independent ATPase activities.
Results
Aldosterone Status
Plasma aldosterone level was significantly increased in adre-
nal-intact PAN-nephrotic rats at day 6 (control 661  123 pM,
n  6; PAN 3871  240 pM, n  7; P  0.001) but less than in
Na-depleted rats (11773  1757 pM, n  9; P  0.001 versus
control, P  0.025 versus PAN). In corticosteroid-clamped ani-
mals, plasma aldosterone was two-fold lower than in control
adrenal-intact rats (288 105 pM, n 5; P 0.05 versus control
adrenal-intact). As expected, PAN treatment no longer in-
creased plasma aldosterone in corticosteroid-clamped rats
(283  57, n  13).
Electrical Activity of ENaC
The electrical activity of ENaC was characterized in cell-
attached patches by the following criteria: Only inward cur-
Figure 3. Subcellular localization of -, -, and -ENaC subunits in connecting tubules (CNT). Indirect immunofluorescent staining
of representative CNT profiles for the three subunits of ENaC in control, PAN-nephrotic, and Na-depleted adrenal-intact and
corticosteroid-clamped rats. In adrenal-intact control rats, staining for the three subunits is diffuse within the CNT cells, whereas
in both PAN-nephrotic and Na-depleted rats, the staining is condensed at the apical pole of the CNT cells. In corticosteroid-
clamped rats, the staining for all three subunits is diffuse in both control and nephrotic rats. Unstained cells in CNT profiles are
intercalated cells. Bar is approximately 40 m.
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rents were observed over the range of potentials tested (80 to
80 mV); single-channel conductance was in the 6- to 10-pS
range in the presence of 145 mM LiCl in the pipette; and the
channel kinetics, as estimated qualitatively, were slow (16,17).
The conductive properties of ENaC recorded in adrenal-
intact control, PAN-nephrotic, and Na-depleted rats were
similar in terms of unitary conductance (approximately 10 pS)
and apparent reversal potential in cell-attached patches (ap-
proximately 55 mV; Table 1). In contrast, the frequency of
ENaC was variable between groups (Figure 1). In control CCD,
ENaC were detected on five (9.6%) of 52 occasions. Although
this disagrees somehow with previous studies that reported no
active ENaC in control Na-replete rats (18), it is worth noting
that the frequency of ENaC remained low and the number of
channels per patch was always 4. As previously reported
(18,19), the frequency of patches with ENaC increased greatly
in Na-depleted rats (12 of 27, 44.4%), and the number of
channels per patch was 4 in two of three of the patches. The
situation was intermediate in CCD from PAN-nephrotic rats,
with 18.6% of patches (eight of 43) that contained ENaC and
50% of the patches with more than four channels. Statistical
comparison between control and PAN-nephrotic animals that
was assessed by comparing the distribution of the total number
of recorded ENaC with an expected equal distribution between
the two groups showed a significant difference (P 0.001). The
open state probability (Po) was close to 0.4 in the three condi-
tions, fitting with previous findings during hyperaldosteron-
emia (17–19).
The functional expression of ENaC was not significantly
altered by corticosteroid clamp in terms of percentage of
patches with ENaC (10 versus 9.6% in corticosteroid-clamped
versus adrenal-intact rats), number of ENaC per patch (1.7 0.6
versus 2.8  1.1; Figure 1), and intrinsic properties of ENaC
(conductance, reversion potential, and open state probability;
Table 1). In corticosteroid-clamped rats, PAN decreased the
density of ENaC, as a single channel was detected in 32 (3%)
patches. In addition, this channel exhibited a very low Po
(0.1). Given this very low occurrence, we could not determine
accurately the properties of this channel, and one might even
question whether it was actually an ENaC.
Subcellular Distribution of -, -, and -ENaC Subunits
Preliminary studies showed that immunostaining by the
three antibodies was blocked by preincubation of the antibody
with the respective immunogenic peptide (Figure 2). The three
subunits of ENaC were detectable in the renal cortex from the
three groups of adrenal-intact rats. In normal rats, -ENaC was
predominantly seen in connecting tubules (CNT), and CCD
exhibited a very faint immunostaining (Figures 2 and 3),
whereas PAN-nephrotic and Na-depleted rats displayed in-
tense immunostaining in both CNT and CCD. As previously
described (3,8,20), in control rats, -ENaC immunostaining was
weak at the apical membrane, and - and -ENaC were seen
predominantly in intracellular compartments. In contrast, in
both PAN-nephrotic and Na-depleted rats, all three ENaC
subunits were well detectable at the apical cell side (Figure 3).
As expected from the expression of ENaC in the segment-
specific CNT and CCD cells but not intercalated cells, the three
subunits of ENaC were detected in a subset of the epithelial
cells that line the CNT and CCD in the three groups of rats. In
corticosteroid-clamped rats, immunohistochemistry confirmed
the lack of activation of ENaC in the distal nephron of PAN-
treated rats, as the immunostaining for ENaC remained faint
and mainly intracellular for all three subunits (Figure 3).
Expression of -, -, and -ENaC mRNA
Na depletion increased the abundance of - and - but not
-ENaC mRNA (Figure 4). PAN nephrosis induced qualita-
tively similar effects on ENaC mRNA, although increase in
-ENaC mRNA did not reach statistical significance. Expres-
sion of ENaC mRNA was no longer increased in corticosteroid-
clamped PAN-nephrotic rats (Figure 4). Corticosteroid clamp
also prevented the increase in serum- and glucocorticoid-in-
duced kinase (sgk) mRNA observed in adrenal-intact nephrotic
and Na-depleted rats (Figure 4).
Electrophoretic Mobility of -ENaC
In Western blot of kidney cortex from adrenal intact rats,
anti–-ENaC stained two main bands of approximately 83 and
Figure 4. Expression of -, -, and -ENaC and sgk mRNA in
CCD from adrenal-intact and corticosteroid-clamped rats. Ex-
pression of mRNA encoding the three subunits of ENaC and
sgk was determined by reverse transcription followed by real-
time PCR on CCD dissected from control (), PAN-nephrotic
(f), or Na-depleted rats (o). For all samples, the amount of
PCR product was calculated as percentage of the standard
RNA. Results (arbitrary unit per mm tubule length) are ex-
pressed as means  SEM from five to 11 animals. Values that
were statistically different from controls were determined by
variance analysis: *P  0.05; **P  0.005. Note that comparison
of expression levels of two different transcripts is meaningless.
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70 kD in the three groups of rats (Figure 5). As previously
reported (3,8), the density ratio of the 83-/70-kD bands was
significantly decreased in PAN-nephrotic and Na-depleted
rats as compared with controls (mean  SEM, n  6 in each
group; control 4.18  0.58; PAN-nephrotic 1.09  0.18, P 
0.001; low-Na 0.68  0.07, P  0.001). In corticosteroid-
clamped rats, the 70-kD band was undetectable in all six rats of
the control and PAN-treated groups. In the five groups of rats,
an additional low molecular weight (approximately 50 kD)
band was detected in some but not all rats. All signals that were
detected by the anti–-ENaC antibody disappeared when the
antibody was preincubated with the immunogenic peptide
(Figure 2).
Renal Handling of Sodium
PAN-induced changes in the profile of sodium excretion and
sodium balance were similar in adrenal-intact and corticoste-
roid-clamped rats except at day 2, when both parameters were
normal in the latter group (Figure 6). In both adrenal-intact and
corticosteroid-clamped rats, proteinuria appeared at day 4 after
PAN administration and rose rapidly up to day 6.
At day 6, adrenal-intact and corticosteroid-clamped PAN-
nephrotic rats displayed similar volumes of ascites ranging 1 to
14 ml (mean SEM 6.0 2.0 ml; n 7) and 1 to 12 ml (mean
SEM 6.0  1.0; n  13) in the two groups, respectively. In
adrenal-intact rats, there was no correlation between the vol-
ume of ascites and the plasma aldosterone level at day 6.
Mechanism of Sodium Retention in Corticosteroid-Clamped
Nephrotic Rats
The absence of ENaC activation in CCD of corticosteroid-
clamped nephrotic rats raises the questions of the site and
cellular mechanism of sodium retention in these rats. In
corticosteroid-clamped nephrotic rats, Na,K-ATPase ac-
tivity was increased in the CCD (Figure 7), as previously
observed in adrenal-intact rats (13). Also, PAN nephrosis
increased the expression of Na,K-ATPase 1 subunit
mRNA in CCD from adrenal-intact and corticosteroid-
clamped rats (Figure 8). Finally, within 1 d, amiloride treat-
ment (1 mg/kg per d) fully reversed PAN-induced sodium
retention (Figure 9) and ascites in corticosteroid-clamped
rats. Altogether, these results indicate that in both adrenal-
intact and corticosteroid-clamped nephrotic rats, sodium re-
tention originates at least in part from the collecting duct and
Figure 5. Immunoblots of -ENaC subunits in kidney cortex from adrenal-intact and corticosteroid-clamped rats. The figure shows
two representative immunoblots with three animals from each group. In adrenal-intact rats, PAN nephrosis and Na depletion
induce a shift of the migration profile with decreased and increased density of the 83- and 70-kD bands, respectively. In
corticosteroid-clamped rats, the 70-kD band was not detectable in both control and nephrotic rats. Note that an additional band
migrating at approximately 50-kD band was detected in some animals from all groups.
Figure 6. Renal excretion of sodium and protein and sodium balance
in the early phase of PAN nephrosis in adrenal-intact and corticoste-
roid-clamped rats. Time course of 24-h urinary Na excretion (A),
protein excretion (B), and Na balance (C) in adrenal-intact and
corticosteroid-clamped rats after a single injection of PANat day 0 (F
and f) or controls (E and). Results at day 0 correspond to the 24-h
urine sample collected the day before PAN injection. Na and pro-
tein excretion are normalized to creatinine excretion. Values are
means  SEM from five rats.
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is accounted for primarily by induction of Na,K-ATPase.
It is worth noting that corticosteroid-clamped rats were
much more sensitive to amiloride than adrenal-intact rats: At
the dose of 20 mg/kg per d amiloride used in our previous
study in adrenal-intact PAN-treated rats (2), all corticoste-
roid-clamped nephrotic rats died within 48 h with symptoms
of severe volume contraction.
Discussion
Our results confirm the previously reported activation of
kidney ENaC in PAN nephrosis (3) and further document its
mechanism. In PAN-nephrosis, ENaC was activated in CCD by
the same mechanism as in hyperaldosteronemia: In both con-
ditions, the functional activity of ENaC was increased in CCD
without change of its intrinsic properties. Increased ENaC ac-
tivity was accounted for by the recruitment of intracellular
ENaC to the apical membrane. Whether membrane recruitment
of ENaC is associated with de novo synthesis of channel units
remains difficult to address in vivo, in the absence of protein
metabolic labeling. At variance with a previous report (11), our
results show an increased level of -ENaC mRNA in CCD from
PAN-nephrotic rats. At the protein level, there are also discrep-
ancies in the literature as Audige´ et al. (11) reported increased
amounts of -ENaC and no change in - and -ENaC in the
kidney cortex of PAN-nephrotic rats, whereas Kim et al. (3)
described no change in - and -ENaC abundance and an
increase of -ENaC. From these data, it can be concluded that
recruitment of pre-existing ENaC is the main cause of increased
ENaC activity in PAN nephrosis.
Altogether, these findings suggest that hyperaldosteronemia
accounts for the stimulation of ENaC in PAN nephrosis. This
conclusion was fully confirmed by the finding that preventing
hyperaldosteronemia in PAN-nephrotic rats by corticosteroid
clamp prevented the activation of ENaC and its recruitment to
the apical membrane. It is interesting that there was a linear
correlation between plasma aldosterone level and the density of
ENaC in the apical membrane (Figure 10). In contrast, the
correlation between plasma aldosterone and sgk mRNA was
weak (Figure 10), suggesting that aldosterone-induced recruit-
ment of ENaC may be accounted for only in part by induction
of sgk.
Recruitment of intracellular ENaC to the apical membrane is
associated with a change in the electrophoretic profile of
-ENaC, in both hyperaldosteronemia (8) and PAN nephrosis
(3). Our results confirm these findings, as the relative abun-
dance of the 70-kD form of -ENaC increased at the expense of
the 83-kD form. Again, there was a good correlation between
plasma aldosterone level and the molecular weight shift of
Figure 7. Na,K-ATPase activity along the nephron of corticosteroid-clamped rats. Na,K-ATPase activity was determined in
the different segments of nephron of control rats () and rats that received an injection of PAN 6 d before the experiment (f).
Values are means  SEM from five control and four nephrotic rats. Values that were statistically different from controls were
determined by t test for unpaired data: **P  0.001.
Figure 8. Expression of Na,K-ATPase mRNA in CCD from
adrenal-intact and corticosteroid-clamped rats. Expression of
mRNA encoding Na,K-ATPase 1 subunit was determined
by reverse transcription followed by real-time PCR on CCD
that were dissected from control (), PAN-nephrotic (f), or
Na-depleted rats (o). For all samples, the amount of PCR
product was calculated as percentage of the standard RNA.
Results (arbitrary unit per mm tubule length) are expressed as
means  SEM from five to 10 animals. Values that were statis-
tically different from controls were determined by variance
analysis: **P  0.001.
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-ENaC, although some saturation appeared at high aldoste-
rone concentration (Figure 10).
In aldosterone-clamped rats, PAN treatment not only failed
to recruit ENaC to the apical membrane but also altered the Po
of pre-existing ENaC. Such a change in Po, which probably
reflects partial degradation of the channels, was induced by
PAN and not by corticosteroid clamp per se and was not seen in
adrenal-intact rats. This decrease in Po is likely accounted for by
a toxic effect of PAN also revealed by the transient increase in
sodium excretion and decrease in Na,K-ATPase activity (13)
observed at day 1. A transient degradation of ENaC present in
apical membranes can be rapidly compensated by recruitment
of nondegraded intracellular ENaC in adrenal-intact animals
but not in corticosteroid-clamped ones. Partial degradation of
ENaC may also account for (1) the decreased abundance of
functional channels and (2) the high amiloride sensitivity ob-
served in corticosteroid-clamped, PAN-nephrotic animals.
In contrast, corticosteroid clamp did not prevent PAN-
induced stimulation of Na,K-ATPase in CCD. In addition, as
previously demonstrated in adrenal-intact rats, this stimulation
is accounted for by de novo synthesis of the pump. These find-
ings confirm previous reports of increased Na,K-ATPase
activity in CCD of adrenalectomized PAN-nephrotic rats (4).
They also indicate that induction of Na,K-ATPase in PAN
nephrosis is independent not only of aldosterone but also of
sgk, the induction of which was prevented in corticosteroid-
clamped rats. The signaling mechanism linking Na,K-AT-
Pase induction and PAN nephrosis remains to be elucidated.
The most striking result of this study was that, in corticoste-
roid-clamped rats, PAN continued to induce amiloride-sensi-
tive retention of sodium despite the decreased number and Po
of ENaC, indicating that induction of Na,K-ATPase is suffi-
cient to increase sodium reabsorption. This means that in-
creased activity of Na,K-ATPase at the basolateral pole of
the cells is able to reduce sufficiently the intracellular sodium
concentration so as to generate a driving force across the apical
membrane sufficient to compensate its markedly reduced con-
ductance to sodium. With this regard, it is noticeable that
Na,K-ATPase in CCD displays a very high affinity for so-
Figure 9. Effect of amiloride on urinary sodium excretion in corticosteroid-clamped PAN-nephrotic rats. Time course of 24-h
urinary Na and protein excretion (solid and dotted lines, respectively) in corticosteroid-clamped rats after a single injection of
PAN at day 0. Results at day 0 correspond to the 24-h urine sample collected the day before PAN injection. Starting after the fourth
24-h urine collection, part of the rats received amiloride (1 mg/kg per d) in the food (F, f). Na and protein excretion are
normalized to creatinine excretion. Values are means  SEM from five rats.
Figure 10. Correlations between plasma aldosterone level and
expression of sgk mRNA, ENaC abundance, and shift in mo-
lecular weight of -ENaC in different groups of rats. This figure
summarizes data corresponding to the three groups of adrenal-
intact rats and control corticosteroid-clamped rats. Data for sgk
mRNA expression (pecked line, arbitrary units) are from Figure
4. ENaC abundance (solid line, absolute values) was calculated
as the ratio between the total number of channels detected by
patch clamp and the total number of patches. The shift in
-ENaC molecular weight (dotted line, absolute values) was
calculated as the mean density ratio of the 70-/83-kD bands.
Results for ENaC abundance and shift in -ENaC molecular
weight were fitted using SigmaPlot to linear (r2  0.999) and
Michaelis plot (r2  0.997), respectively, whereas data for sgk
mRNA expression did not fit satisfactorily to any usual plot.
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dium (21), therefore allowing the maintenance of a high activity
at low intracellular sodium concentration. This demonstrates
that in such circumstances, apical ENaC is far from being the
rate-limiting step of sodium reabsorption in CCD. Such a con-
clusion was recently reached in mouse CCD in response to
ERK1,2 activation (22).
In conclusion, at the time of renal sodium retention and
ascites, PAN-nephrotic rats exhibit increased apical ENaC ac-
tivity that results from hyperaldosteronemia-induced recruit-
ment of an intracellular pool of channels. However, activation
of ENaC appears as an epiphenomenon that is not necessary for
full activation of transepithelial sodium reabsorption, as long as
some residual ENaC activity remains in the apical membrane.
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